Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 01:05PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-29.08 Insider Own1.59% Shs Outstand3.06M Perf Week30.74%
Market Cap19.00M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.01M Perf Month-9.87%
Income-18.05M PEG- EPS next Q- Inst Own1.89% Short Float0.01% Perf Quarter-25.00%
Sales2.37M P/S8.02 EPS this Y- Inst Trans57.37% Short Ratio0.03 Perf Half Y-29.43%
Book/sh42.74 P/B0.15 EPS next Y- ROA-43.46% Short Interest0.00M Perf Year-46.09%
Cash/sh9.66 P/C0.64 EPS next 5Y- ROE-81.71% 52W Range3.96 - 12.80 Perf YTD-16.53%
Dividend Est.- P/FCF- EPS past 5Y- ROI-138.31% 52W High-51.48% Beta1.59
Dividend TTM- Quick Ratio5.93 Sales past 5Y103.89% Gross Margin83.40% 52W Low56.82% ATR (14)0.61
Dividend Ex-Date- Current Ratio5.94 EPS Y/Y TTM-45.04% Oper. Margin-838.71% RSI (14)51.66 Volatility16.77% 10.03%
Employees21 Debt/Eq0.02 Sales Y/Y TTM-62.02% Profit Margin-760.32% Recom1.00 Target Price60.00
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q-440.73% Payout- Rel Volume0.55 Prev Close6.84
Sales Surprise- EPS Surprise- Sales Q/Q-99.81% EarningsMay 16 BMO Avg Volume11.97K Price6.21
SMA2015.52% SMA50-12.69% SMA200-17.68% Trades Volume3,966 Change-9.21%
Date Action Analyst Rating Change Price Target Change
Jul-19-17Reiterated Maxim Group Buy $2 → $4
May-10-17Reiterated H.C. Wainwright Buy $7.50 → $3
May-01-17Reiterated Maxim Group Buy $11 → $2
Jan-17-17Reiterated Maxim Group Buy $7 → $10
Dec-02-15Reiterated H.C. Wainwright Buy $11 → $12
Nov-24-15Reiterated H.C. Wainwright Buy $0.11 → $11
Nov-23-15Reiterated Maxim Group Buy $200 → $11
Apr-14-15Upgrade H.C. Wainwright Neutral → Buy $1.25
Nov-06-14Downgrade H.C. Wainwright Buy → Neutral
Jul-17-14Initiated H.C. Wainwright Buy $3
Jun-13-24 09:10AM
Jun-03-24 09:15AM
May-29-24 06:35PM
May-17-24 08:49AM
07:53AM Loading…
May-15-24 07:53AM
May-14-24 09:01PM
May-01-24 07:55AM
Apr-28-24 12:01PM
Mar-28-24 07:55AM
Mar-27-24 01:52PM
08:05AM Loading…
Mar-12-24 02:10PM
Feb-26-24 07:30AM
Feb-15-24 05:50PM
Dec-14-23 08:16AM
Nov-09-23 08:32AM
Oct-18-23 10:00AM
Oct-11-23 08:00AM
Sep-05-23 08:00AM
Aug-09-23 09:40AM
07:30AM Loading…
Jul-13-23 07:30AM
Jul-05-23 08:45AM
Jun-14-23 04:05PM
May-15-23 04:05PM
May-10-23 05:03AM
May-09-23 05:00PM
Apr-06-23 10:15AM
Apr-05-23 07:55AM
Mar-23-23 09:25AM
Mar-16-23 08:05AM
Feb-23-23 09:40AM
Feb-07-23 09:40AM
Jan-17-23 12:53PM
Jan-11-23 01:00PM
Jan-10-23 08:05AM
Nov-03-22 10:15AM
Aug-29-22 08:00AM
Aug-03-22 05:30PM
Jul-28-22 10:02AM
Jul-18-22 05:06PM
Jul-15-22 04:15PM
Jul-06-22 04:05PM
Jun-21-22 04:01PM
Jun-13-22 08:00AM
Jun-09-22 08:00AM
Jun-03-22 06:58AM
May-25-22 08:00AM
May-18-22 08:00AM
May-16-22 08:00AM
May-12-22 08:05AM
May-11-22 08:05AM
May-02-22 08:25AM
Apr-25-22 08:05AM
Apr-19-22 08:05AM
Apr-13-22 10:45AM
Apr-12-22 08:05AM
Apr-11-22 08:05AM
Mar-29-22 08:00AM
Mar-21-22 05:15PM
Mar-17-22 08:25AM
Mar-15-22 09:15AM
Mar-10-22 07:05AM
Mar-02-22 08:05AM
Mar-01-22 09:05AM
Feb-07-22 08:05AM
Feb-04-22 01:38PM
Jan-26-22 04:05PM
Jan-20-22 08:05AM
Jan-12-22 10:35AM
Jan-05-22 08:36AM
Dec-25-21 08:31AM
Dec-23-21 04:05PM
Nov-04-21 04:05PM
Oct-21-21 07:30PM
Oct-20-21 07:30PM
Oct-01-21 12:46PM
Sep-26-21 08:02AM
Sep-08-21 08:00AM
Aug-04-21 04:05PM
Jul-29-21 08:05AM
Jun-28-21 01:56AM
Jun-13-21 02:10PM
Jun-07-21 08:05AM
Aeterna Zentaris, Inc. is a specialty biopharmaceutical company, which engages in the development and commercialization of therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.